Germany · Funded startup

Who invested in Implisense

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & Analytics

Funding summaryUpdated 26 Oct 2026

$612Kraised across 2 rounds since 2015, from 2 sources

$500KSeed$112KGrant
Latest round
Grant, $112KMay 2016
Biggest round
$500KSeed · Feb 2015
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2016
$500KSeed$112KGrant
First round
Seed, $500K
Feb 2015
Biggest round
$500K
Seed · Feb 2015
Between rounds
15 months
from the last two

The rounds

  1. May 2016
    Grant$112K

    No investor was named in the report.

    Source recorded

  2. Feb 2015
    Seed$500K1 new

    From a historical funding record

Founders and team

From Implisense's own website: 1 founder, 2 on the team.

Hannes KorteCo-Founder
  • Dr. Andreas SchäferManaging Director
  • Dr. André BergholzManaging Director

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Implisense

Who invested in Implisense?

Implisense's investors include High-Tech Gruenderfonds.

How much has Implisense raised?

Implisense has raised $612K across 2 rounds since 2015.

When did Implisense last raise?

Implisense's most recent round was a Grant of $112K in May 2016.

What was Implisense's biggest round?

Implisense's largest round on record is $500K (Seed), in Feb 2015.

Who backed Implisense first?

Implisense's first round on record, in Feb 2015, was backed by High-Tech Gruenderfonds.

What stage is Implisense at?

Implisense's latest named round is a Grant, in May 2016.

Where is Implisense based?

Implisense is based in Germany.

Companies like Implisense

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.